Fundraising Fox

U.S. Venture Partners β€” Full Portfolio

13 tracked investments Β· listed companies and verified rows first

Adaptive6adaptive6.cominJan 2026 Β· $28M

Adaptive provides a cloud cost optimization platform that detects, remediates, and prevents "shadow waste" and inefficiencies across multi-cloud, Kubernetes, AI platforms, data cloud, and code.

AI & Machine LearningCloud ComputingDeveloper Tools

Aviv Revach(Founder)Eyal Brosh(Founder)

Co-investorsForgePoint CapitalLaunchpad CapitalNew Era Capital PartnersUS Venture PartnersNew Era CapitalPitango+1 more

Cagent Vascularcagentvascular.cominJun 2026 Β· $41M

Cagent Vascular develops endovascular medical devices, including the Serranator PTA Serration Balloon Catheter, for the treatment of vascular disease.

HardwareHealthtechMedical DevicesWayne, US

Brian Walsh(Chairman & CEO)inPeter Johansson(Chief Quality & Compliance Officer, VP Engineering)inPaul Wilson(Chief Commercial Officer)inMatt Condron(SVP of Operations)inCorey Latanision(SVP of Marketing & International Sales)inPeter Schneider(Chief Medical Advisor, Co-Founder)

Co-investorsUS Venture PartnersAstoria Health Investors

Impervaimperva.comin𝕏Acquired

Imperva provides cybersecurity solutions to protect customers from cyberattacks across applications, data, and identities during digital transformation.

CybersecurityEnterprise SoftwareSan Mateo, US

Shlomo Kramer(Co-Founder, President & CEO (early years))Amichai Shulman(Co-Founder & CTO)Mickey Boodaei(Co-Founder)Pam Murphy(CEO)Chris Hylen(President & CEO)Charles Goodman(Interim CEO)

Co-investorsAccelAspect VenturesCore Ventures GroupDigi VenturesForgePoint CapitalSAV (Scale Asia Ventures)+6 more

Luminopialuminopia.comin𝕏Jun 2023 Β· $16M

Luminopia is an FDA-cleared binocular therapy for amblyopia in children aged 4-12 that uses a VR headset to stream the child's favorite TV shows as treatment, replacing traditional eye patches.

BiotechDigital HealthHealthtechMedical DevicesAspen, US

DEAN A. TRAVERS(Executive Officer, Director)SCOTT XIAO(Executive Officer, Director)Scott Xiao(Co-Founder & CEO)Dean Travers(Co-Founder)Brion Raymond(CBO)Drew Mowery(VP of Commercial Strategy)

Co-investorsShangBay Capital LLCBantam GroupGood FriendsNXT VenturesSony Ventures CorporationUS Venture Partners

NuXcelnuxcel.comOct 2024 Β· $66M

NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model.

Deep TechHealthtechMedical Devices

Co-investorsTreo Ventures, LlcAmzak HealthAPERTURE Venture PartnersNorwest Venture PartnersOSF Ventures

Perceptopercepto.coin𝕏Jun 2023 Β· $67M

Percepto develops autonomous drone ("drone-in-a-box") systems and software for automated inspection and continuous monitoring of critical industrial infrastructure.

AI & Machine LearningEnergyIoTRobotics

Dor Abuhasira(Co-founder & CEO)inAriel Avitan(Co-founder)inSagi Blonder(Co-founder, Head of R&D)inRaviv Raz(Co-founder)inUdi Zohar(Chief Product Officer)inNir Simon(CFO)in

Co-investorsAtento CapitalBeast VenturesCourtside VenturesEmerge VenturesHTwentyKoch Disruptive Technologies+5 more

ShiraTronicsshiratronics.cominOct 2024 Β· $66M

ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.

BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US

Robert Binney(Executive Officer, Director)

BoardJoyce Erony(Director)inZack Scott(Director)Brad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)

Co-investorsAmzak HealthAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF Ventures+3 more

Simpleesimplee.comin𝕏acquired by Flywire

Simplee was a healthcare financial technology company that provided a patient financial engagement platform, helping hospitals and health systems offer transparent billing, estimates, and payment experiences.

Enterprise SoftwareFintechSaaSPalo Alto, US

Tomer Shoval(Co-Founder & CEO)Roberto Rabinovich(Co-Founder & COO)Tom Tsarfati(Co-Founder & CTO)Derick Sutton(Chief Financial Officer)John Dwight(Executive (role unconfirmed))Joel Haferbecker(Executive (role unconfirmed))

Co-investors83NorthGreylock Partners

Smartlingsmartling.comin𝕏Oct 2023 Β· $10M

Smartling provides enterprise-grade localization and translation software with APIs, SDKs, and CI/CD integrations for software development teams.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareMarketing TechSaaS

Jack Welde(Founder)in

Co-investorsAccelerator VenturesBattery VenturesHarmony PartnersICONIQRidge VenturesTenaya Capital+4 more

Surgical Safety TechnologiesMay 2023

New York, US

Teodor P. Grantcharov(Executive Officer, Director)

BoardPeter Charbonneau(Director)Jonathan Root(Director)inDennis McWilliams(Director)Dafina Toncheva(Director)inHartley Stern(Director)

Co-investorsUS Venture Partners

Trust Labtrustlab.cominJun 2023 Β· $15M

TrustLab provides AI-powered Trust and Safety solutions for internet platforms to combat abuse, protect user privacy, and ensure brand safety.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaSSan Francisco, US

Tom(Founder & CEO)Shankar(Co-Founder & CTO)inBenji Loney(Founder)Shankar Ponnekanti(Founder)Tom Siegel(Founder)Benji(CPO)in

Co-investorsInner Loop CapitalNext Frontier CapitalFoundation Capital

Zerozero.tech𝕏Jun 2025 Β· $55M

ZERO is a decentralized, privacy-focused messaging and social platform, offering products including a messenger, social app, and digital identity (Zero ID) built on a crypto protocol with its own token.

ConsumerCrypto & Web3Social

Co-investorsRed Beard VenturesF2 Venture CapitalHighland EuropePICO Venture PartnersVenrock

Zero Networkszeronetworks.comin𝕏Dec 2023 Β· $55M

Zero Networks provides a microsegmentation platform that applies zero trust access controls across networks and identities.

CybersecurityEnterprise SoftwareSaaSTel Aviv, IL

Benny Lakunishok(Co-Founder & CEO)

Co-investorsF2 Venture CapitalHighland EuropeUS Venture PartnersVenrockPICO Venture Partners

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.